Vyvyan C. Salisbury

Efficacy Profiles of Daptomycin for Treatment of Invasive and Noninvasive Pulmonary Infections with <i>Streptococcus pneumoniae</i>

Stefanie Henken, Jennifer Bohling, Jens Martens‐Lobenhoffer et al. · Antimicrobial Agents and Chemotherapy · 2009 · 37 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin

Vyvyan C. Salisbury, Andreas Pfoestl, Herbert Wiesinger-Mayr et al. · Journal of Antimicrobial Chemotherapy · 1999 · 34 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms

Cláudia N. H. Marques, Vyvyan C. Salisbury, John Greenman et al. · Journal of Antimicrobial Chemotherapy · 2005 · 31 citations · Full text

Life Sciences, Microbiology, Biophotonics +16

Biofilm culture of Pseudomonas aeruginosa expressing lux genes as a model to study susceptibility to antimicrobials

Abida Parveen, Gillian Smith, Vyvyan C. Salisbury et al. · FEMS Microbiology Letters · 2001 · 23 citations

Life Sciences, Microbiology, Bacteriology +16

Evaluation of Biophotonic Imaging To Estimate Bacterial Burden in Mice Infected with Highly Virulent Compared to Less Virulent <i>Streptococcus pneumoniae</i> Serotypes

Stefanie Henken, Jennifer Bohling, Abiodun D. Ogunniyi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17